Overview Trial to Evaluate the Efficacy and Safety of HCP1302 Status: Completed Trial end date: 2015-08-01 Target enrollment: Participant gender: Summary Trial to Evaluate the Efficacy and Safety of HCP1302 Phase: Phase 3 Details Lead Sponsor: Hanmi Pharmaceutical Company Limited